PCRX PACIRA BIOSCIENCES INC
FollowStock (common), issuer CIK 1396814
229 managers (234 13F filers) reported a position in PCRX shares at 2025-06-30, 50,534,869 shares in all. 29 filers opened a position and 32 filers sold out during the quarter.
- Managers
- 229
- 13F filers
- 234
- New
- 29
- Added
- 84
- Reduced
- 77
- Sold out
- 32
- Shares held by filers
- 50,534,869
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Doma Perpetual Capital Management LLC
0 shares, 0% in a 13D/A as of 2026-10-08,0001104659-26-115589
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| RIKER LAURENofficer (Senior Vice President, Finance) | 2026-10-08 | -6,000 S | $36.32 | Form 4 |
| RIKER LAURENofficer (Senior Vice President, Finance) | 2026-10-08 | +6,000 M | $32.35 | Form 4 |
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Doma Perpetual Capital Management LLC and 6 other reporting persons reported 0 PCRX shares, 0% of the class, as of 2026-10-08, in a 13D/A filed 2026-10-13. 0001104659-26-115589
Accepted , ingestedRIKER LAUREN reported transactions in PCRX shares with no net change in a Form 4 filed 2026-10-09. 0001628280-26-065566
Accepted , ingested